Definitive Healthcare (NASDAQ:DH) Downgraded to “Strong Sell” Rating by Zacks Research

Definitive Healthcare (NASDAQ:DH) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Thursday,Zacks.com reports.

A number of other brokerages have also issued reports on DH. Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Canaccord Genuity Group dropped their price objective on Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a report on Friday, February 27th. Morgan Stanley restated an “underperform” rating and issued a $3.50 price objective on shares of Definitive Healthcare in a research note on Thursday, December 18th. William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a research report on Thursday, November 6th. Finally, Barclays cut their price target on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating for the company in a report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $3.52.

Definitive Healthcare Stock Down 3.3%

DH stock opened at $1.18 on Thursday. The firm has a market cap of $166.80 million, a PE ratio of -0.94 and a beta of 1.66. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. Definitive Healthcare has a one year low of $1.07 and a one year high of $4.70. The firm’s 50 day moving average price is $2.04 and its 200-day moving average price is $2.79.

Institutional Trading of Definitive Healthcare

Several large investors have recently modified their holdings of DH. State of Alaska Department of Revenue raised its position in shares of Definitive Healthcare by 109.3% during the 4th quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock worth $32,000 after purchasing an additional 5,970 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Definitive Healthcare during the 2nd quarter valued at $32,000. Schonfeld Strategic Advisors LLC purchased a new position in Definitive Healthcare during the fourth quarter worth $35,000. Savant Capital LLC acquired a new position in shares of Definitive Healthcare in the second quarter worth $45,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Definitive Healthcare in the fourth quarter valued at $46,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.